LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.31623
 46.95 84.90 1105 4952 0.2231 0.5487
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 46.95 84.90 349 4952 0.0705 0.2725
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 46.95 84.90 824 4952 0.1664 0.4732
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 48.65 84.90 1085 5328 0.2036 0.5321
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 48.65 84.90 1111 5328 0.2085 0.5382
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 48.65 84.90 347 5328 0.0651 0.2659
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 48.65 84.90 855 5328 0.1605 0.4722
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 50.36 84.90 1048 5651 0.1855 0.5143
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 50.36 84.90 1084 5651 0.1918 0.5228
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 50.36 84.90 396 5651 0.0701 0.2895
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 50.36 84.90 906 5651 0.1603 0.4783
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 52.06 84.90 1067 5990 0.1781 0.5101
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 52.06 84.90 1110 5990 0.1853 0.5199
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 52.06 84.90 391 5990 0.0653 0.2824
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 52.06 84.90 895 5990 0.1494 0.4675
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 53.77 84.90 1096 6252 0.1753 0.5104
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 53.77 84.90 1133 6252 0.1812 0.5186
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 53.77 84.90 334 6252 0.0534 0.2471
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 53.77 84.90 857 6252 0.1371 0.4517
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 55.48 84.90 1126 6567 0.1714 0.5099
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 55.48 84.90 1159 6567 0.1765 0.5169
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 55.48 84.90 380 6567 0.0579 0.2699
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 55.48 84.90 880 6567 0.1340 0.4517
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 57.18 84.90 1118 6963 0.1606 0.5000
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 57.18 84.90 1143 6963 0.1641 0.5052
MN20160318_Q02
D08